UPC - Universe Pharmaceuticals PEG multiplikatori

Doriyalarning sifati bo'yicha nazoratning kuchayishi xavflari noaniqlikni yuzaga keltirmoqda, buni GURU.Markets platformasining EPS o'sishi uchun moslashtirilgan kundalik P/E grafigi tebranishlar orqali vizuallashtiradi, bunda 0.00 belgisi Universe Pharmaceuticals (UPC) uchun so'nggi ma'lumotlarni aks ettiradi. Fundamental jihatdan, biznes o'simliklar asosidagi retseptlarga bo'lgan barqaror talabga tayanadi, garchi mintaqaviy kengayish mahalliy dorixonalarning yuqori zichligi tufayli cheklangan bo'lsa-da.

UPC (Universe Pharmacy) PEG multiplikatori tarixi 04.07.2022dan 12.11.2026gacha

Universe Pharmaceuticals (UPC) kompaniyasining tahliliy kesimlari

- joriy kotirovkalar va o'rtacha qiymat prognozi:

Birja narxi Universe Pharmaceuticals Inc.|UPC - Konsensus maqsadli narx

- bozor kapitallashuvi statistikasi:

Bozor kapitallashuvi Universe Pharmacy|UPC - Kompaniyaning to‘liq qiymati

- balans bo'yicha xususiy kapital ma'lumotlari:

Bitta aksiya hisobiga xususiy kapital Universe Pharmaceuticals|UPC - Balans kapitallashuvi|Balans qiymatiga nisbatan bozor kapitallashuvi universe-pharmacy.com|UPC - Kompaniyaning yakuniy aktivlari

- emitentning kredit yuki va likvidlik ko'rsatkichlari:

Qarzning xususiy kapitalga nisbati Universe Pharmaceuticals|UPC - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli majburiyatlarning kapitalga nisbati universe-pharmacy.com|UPC - Kompaniya qarzlari|Qarzning sof aktivlarga nisbati Universe Pharmacy|UPC - Kompaniyaning uzoq muddatli qarzi|Qisqa muddatli qarz hajmi Universe Pharmaceuticals|Shoshilinch likvidlik universe-pharmacy.com

- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:

UPC - Sof daromad|Kutilayotgan sof daromad Universe Pharmaceuticals|UPC - Narxning foydaga nisbati|Narxning kutilayotgan foydaga nisbati Universe Pharma|UPC - PEG multiplikatori|Biznes qiymatining amortizatsiya chegirilishidan oldingi operatsion foydaga nisbati Universe Pharmacy|UPC - EBITDA operatsion foydasi|Bir aksiya uchun sof foyda (EPS TTM) Universe Pharmaceuticals|UPC - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi 12 oy davomida bitta aksiya uchun foydaning yillik o'sishi universe-pharmacy.com|UPC - Joriy yilda bir aksiya uchun foyda o'sishi|Keyingi yil uchun bir aksiya uchun kutilayotgan foyda o'sishi Universe Pharmaceuticals

Kompaniyaning fundamental tahlili:Universe Pharmaceuticals Inc., UPC

Universe Pharmaceuticals (UPC) ning kredit sifatini baholash uchun, PEG koeffitsienti orqali aks etgan bozor qiymatini foyda dinamikasi bilan solishtirish juda muhimdir. Xitoydagi qat'iy davlat narxlar tartibga solish choralari va generik dori vositalari marjasiga bo'lgan bosim fonida, birdan past koeffitsient aktivning kengayish sur'atlariga nisbatan fundamental past baholanganligidan dalolat beradi.

Universe Pharmaceuticals raqobatchilari

CVS - O‘sish sur’atiga tuzatilgan narx-foyda|McKesson Corp. - Narx-foyda va o‘sish multiplikatori|PEG multiplikatori AmerisourceBergen Corporation COR|CAH - Narxning foydaga va o‘sish sur’atiga nisbati|HSIC (henryschein.com) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PBH: PEG multiplikatori|WGRX - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narx-foyda va o‘sish multiplikatori YI|Narxning foydaga va o‘sish sur’atiga nisbati RDGT|PEG multiplikatori BDRX|HKPD - O‘sish sur’atiga tuzatilgan narx-foyda|Narxning foydaga va o‘sish sur’atiga nisbati BIMI Holdings BIMI|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti CJJD|WBA - Narxning foydaga va o‘sish sur’atiga nisbati